Cited by 352Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets

Open access

Cai, Yongle, Liu, Jingliu, Wang, Bin, Sun, Miao, Yang, Hao·2022·Frontiers in Immunology

DOI 10.3389/fimmu.2022.856376PMC PMC9086828

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease worldwide, characterized by progressive neuron degeneration or loss due to excessive accumulation of β-amyloid (Aβ) peptides, formation of neurofibrillary tangles (NFTs), and hyperphosphorylated tau. The treatment of AD has been only partially successful as the majority of the pharmacotherapies on the market may alleviate some of the symptoms. In the occurrence of AD, increasing attention has been paid to neurodegeneration, while the resident glial cells, like microglia are also observed. Microglia, a kind of crucial glial cells associated with the innate immune response, functions as double-edge sword role in CNS. They exert a beneficial or detrimental influence on the adjacent neurons through secretion of both pro-inflammatory cytokines as well as neurotrophic factors. In addition, their endocytosis of debris and toxic protein like Aβ and tau ensures homeostasis of the neuronal microenvironment. In this review, we will systematically summarize recent research regarding the roles of microglia in AD pathology and latest microglia-associated therapeutic targets mainly including pro-inflammatory genes, anti-inflammatory genes and phagocytosis at length, some of which are contradictory and controversial and warrant to further be investigated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3389/fimmu.2022.856376

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 The role of microglia in AD progression. The clearance of Aβ mediated by microglia contributes to the homeostasis maintenance of CNS. But, with the AD progression, excessive activation of microglia would release excessive pro-inflammatory factors to compromise neurons and their synapses.CC BY · PubMed Central

Figure 2 NLRP3 inflammasome and IDE in microglia of AD. The NLRP3 inflammasome accelerates microglial inflammation and can be inhibited by various substances. The secretion of IDE helps degrade Aβ and is regulated by diverse drugs.CC BY · PubMed Central

Figure 3 NF-κB pathway in microglia of AD. NF-κB signal pathway plays a central role in microglia-mediated neuroinflammation. This figure introduces multiple drugs mentioned in this review above, and their effects on microglia at length via NF-κB signal pathway.CC BY · PubMed Central

Figure 4 Microglial phagocytosis and autophagy in AD. Microglia eliminate Aβ load through phagocytosis and autophagy. This figure displays the regulatory mechanism of this process.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,184
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
The Inflammasome
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244

Show all 169 references

Sorted by citations

Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Microglial Metabolic Reprogramming: Emerging Insights and Therapeutic Strategies in Neurodegenerative Diseases
Miao, J., Chen, L., Pan, X., Li, L.-Q., Zhao, B., & Lan, J. X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01376-y · Cited by 112
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Cohen, J., Mathew, A., Dourvetakis, K. D., Sanchez-Guerrero, E., Pangeni, R. P., Gurusamy, N., Aenlle, K. K., Ravindran, G., Twahir, A., Isler, D., et al. (2024) · Cells · doi:10.3390/cells13060511 · Cited by 103
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
Javanmehr, N., Saleki, K., Alijanizadeh, P., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02637-1 · Cited by 105
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Toader, C., Tătaru, C. P., Munteanu, O., Șerban, M., Covache-Busuioc, R.-A., Ciurea, A. V., & Enyedi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312613 · Cited by 112
Autoimmune Neuroinflammatory Diseases: Role of Interleukins
Khan, A. W., Farooq, M., Hwang, M.-J., Haseeb, M., & Choi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097960 · Cited by 107
Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?
Lista, S., Imbimbo, B. P., Grasso, M., Fidilio, A., Emanuele, E., Minoretti, P., López-Ortiz, S., Martín-Hernández, J., Gabelle, A., Caruso, G., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03163-y · Cited by 81
Lead aggravates Alzheimer's disease pathology via mitochondrial copper accumulation regulated by COX17
Huang, D., Chen, L., Ji, Q., Xiang, Y., Zhou, Q., Chen, K., Zhang, X., Zou, F., Zhang, X., Zhao, Z., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102990 · Cited by 78
Microglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69
Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications
Roveta, F., Bonino, L., Piella, E. M., Rainero, I., & Rubino, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211941 · Cited by 79
Essential Oil Constituents as Anti-Inflammatory and Neuroprotective Agents: An Insight through Microglia Modulation
Stojanović, N. M., Randjelović, P. J., Simonović, M., Radić, M., Todorović, S., Corrigan, M., Harkin, A., & Boylan, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105168 · Cited by 66
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Han, T., Xu, Y., Sun, L., Hashimoto, M., & Wei, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385845 · Cited by 61
Promoting Alzheimer’s disease research and therapy with stem cell technology
Cao, Z., Kong, F., Ding, J., Chen, C., He, F., & Deng, W. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03737-w · Cited by 60
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Popescu, C., Munteanu, C., Anghelescu, A., Ciobanu, V., Spînu, A., Andone, I., Mandu, M., Bistriceanu, R., Băilă, M., Postoiu, R.-L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011272 · Cited by 58
Role of Antioxidants in Modulating the Microbiota–Gut–Brain Axis and Their Impact on Neurodegenerative Diseases
Kurhaluk, N., Kamiński, P., Bilski, R., Kołodziejska, R., Woźniak, A., & Ткаченко, Г. М. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083658 · Cited by 50
Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Sree, R. R., Kalyan, M., Anand, N., Mani, S., Gorantla, V. R., Sakharkar, M. K., Song, B., & Chidambaram, S. B. (2025) · ACS Omega · doi:10.1021/acsomega.4c05527 · Cited by 45
Review of the therapeutic potential of Forsythiae Fructus on the central nervous system: Active ingredients and mechanisms of action
Zhang, L., Lang, F., Feng, J., & Wang, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117275 · Cited by 41
Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms
Abbas, K., Mustafa, M., Alam, M., Habib, S., Ahmad, W., Adnan, M., Hassan, M. I., & Usmani, N. (2025) · Neurogenetics · doi:10.1007/s10048-025-00821-y · Cited by 46
Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
Shen, Y., Zhao, M., Zhao, P., Meng, L., Zhang, Y., Zhang, G., Taishi, Y., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1408462 · Cited by 45
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Chen, H., Zeng, Y., Wang, D., Li, Y., Xing, J., Zeng, Y., Liu, Z., Zhou, X., & Fan, H. J. (2024) · Molecules · doi:10.3390/molecules29071478 · Cited by 41
Physiological and pathological functions of circular RNAs in the nervous system
Zhou, M., Li, S., & Huang, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379017 · Cited by 35
SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options
Yan, M., Sun, Z., Zhang, S., Yang, G., Jiang, X. Y., Wang, G., Li, R., Wang, Q., & Tian, X. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110988 · Cited by 38
The Role of Genetic, Environmental, and Dietary Factors in Alzheimer’s Disease: A Narrative Review
Mertaş, B., & Boşgelmez, İ. İ. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031222 · Cited by 35
The dual role of microglia in Alzheimer’s disease: from immune regulation to pathological progression
He, C., Chen, B., Yang, H., & Zhou, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1554398 · Cited by 40
Self-citation
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
Boraschi, D., Italiani, P., Migliorini, P., & Bossù, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128190 · Cited by 35
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
Balu, D., Valencia-Olvera, A. C., Nguyen, A., Patnam, M., York, J., Peri, F., Neumann, F., LaDu, M. J., & Tai, L. M. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01330-6 · Cited by 27
Common Signaling Pathways Involved in Alzheimer’s Disease and Stroke: Two Faces of the Same Coin
Das, T. K., Ganesh, B. P., & Fatima-Shad, K. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220108 · Cited by 33
Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Dave, B. P., Shah, Y. B., Maheshwari, K. G., Mansuri, M. K. A., Prajapati, B., Postwala, H. I., & Chorawala, M. R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01408-7 · Cited by 33
Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis
Yang, J., Shi, X., Wang, Y., Ma, M., Liu, H., Wang, J., & Xu, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230593 · Cited by 32
Application of Nanobiosensor engineering in the diagnosis of neurodegenerative disorders
Dhahi, T. S., Dafhalla, A. K. Y., Al-Mufti, A. W., Elobaid, M. E., Adam, T., & Gopinath, S. C. B. (2024) · Results in Engineering · doi:10.1016/j.rineng.2024.102790 · Cited by 30
Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
Park, J.-H., Hwang, J.-W., Lee, H., Jang, G. M., Jeong, Y. J., Cho, J., Seo, J., & Hoe, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1150940 · Cited by 29
The immunometabolic reprogramming of microglia in Alzheimerʼs disease
Chen, H., Guo, Z., Sun, Y., & Dai, X. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105614 · Cited by 30
Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights
Junyi, L., Yueyang, W., Liu, B., Xiaohong, D., Wenhui, C., Zhang, N., & Zhang, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04513-w · Cited by 31
Protein palmitoylation: biological functions, disease, and therapeutic targets
Qian, Y., Zhao, Y., & Zhang, F. (2025) · MedComm · doi:10.1002/mco2.70096 · Cited by 32
Microglial dysfunction in Alzheimer's disease: Mechanisms, emerging therapies, and future directions
Azmal, M., Paul, J. K., Prima, F. S., Haque, A. N. M. S. N. B., Meem, M., & Ghosh, A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115374 · Cited by 28
Interplay between microglia and environmental risk factors in Alzheimer's disease
Zhang, M., Liang, C., Chen, X., Cai, Y., & Cui, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389745 · Cited by 29
Self-citation
Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions
Almutary, A. G., Begum, M. Y., Kyada, A., Gupta, S. K., Jyothi, S. R., Chaudhary, K., Sharma, S., Sinha, A., Abomughaid, M. M., Imran, M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102548 · Cited by 28
Korean black ginseng extract alleviates Alzheimer's disease-related cognitive impairment by activating the Nrf2/HO-1 pathway and suppressing the p38 MAPK/NF-κB/STAT3 pathways and NLRP3 inflammasome via TLR2 and TLR4 modulation
Ha, Y., Jo, H.-S., Kwon, T. W., Jeon, S. H., Moon, S., Jung, J. H., Kim, M. S., Nah, S.-Y., Lee, J. K., & Cho, I. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.02.002 · Cited by 28
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Balakrishnan, R., Jannat, K., & Choi, D. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103105 · Cited by 29
Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer’s disease: a focus on signaling mechanisms
Han, J., Zhang, X., Kang, L., & Guan, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03443-1 · Cited by 26
Schisandrin B ameliorates Alzheimer's disease by suppressing neuronal ferroptosis and ensuing microglia M1 polarization
Ding, T., Song, M., Wu, Y., Zhu, L., Zhang, S., & Fan, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156780 · Cited by 28
Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation
Wang, K., Yang, R., Li, J., Wang, H., Wan, L., & He, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591438 · Cited by 27
Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
Xia, J., Dong, S., Yang, L., Wang, F., Xing, S., Du, J., & Li, Z. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106980 · Cited by 25
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy
Fang, M., Zhou, Y., He, K., Lu, Y., Tao, F., & Huang, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04775-y · Cited by 31
YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease
Sun, J., Chen, F., She, L., Zeng, Y., Tang, H., Ye, B., Zheng, W., Xiong, L., Li, L., Li, L., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.020 · Cited by 24
Postbiotics as a therapeutic tool in Alzheimer's disease: Insights into molecular pathways and neuroprotective effects
Aran, K. R., Porel, P., Hunjan, G., Singh, S., Gupta, G. D., & Rohit (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102685 · Cited by 25
A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer’s disease
Atabi, F., Moassesfar, M., Nakhaie, T., Bagherian, M., Hosseinpour, N., & Hashemi, M. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01930-2 · Cited by 36
Low-Dose Radiation Therapy (LDRT) against Cancer and Inflammatory or Degenerative Diseases: Three Parallel Stories with a Common Molecular Mechanism Involving the Nucleoshuttling of the ATM Protein?
Reun, E. L., & Foray, N. (2023) · Cancers · doi:10.3390/cancers15051482 · Cited by 24
Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
Schreiner, O. D., & Schreiner, T. G. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1234958 · Cited by 25
Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer’s Disease: A Recent Systematic Review
Munteanu, C., Iordan, D. A., Hoteteu, M., Popescu, C., POSTOIU, R. L., Onu, I., & Onose, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015481 · Cited by 23
Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease
Flieger, J., Forma, A., Flieger, W., Flieger, M., Gawlik, P. J., Dzierżyński, E., Maciejewski, R., Teresiński, G., & Baj, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168982 · Cited by 27
Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease
Xu, F.-Q., & Shi, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241307404 · Cited by 25
The Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases
Cătălina, G. R., Gheorman, V., Gheorman, V., & Forțofoiu, M.-C. (2025) · Healthcare · doi:10.3390/healthcare13070837 · Cited by 27
Nanobiosensors in neurodegenerative disease diagnosis: A promising pathway for early detection
Yadav, S., Bukke, S. P. N., Prajapati, S., Singh, A. P., Chettupalli, A. K., & Nicholas, B. (2025) · Digital Health · doi:10.1177/20552076251342457 · Cited by 23
Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease
Pati, S., Gautam, A. S., Dey, M., Tiwari, A., & Singh, R. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103750 · Cited by 23
Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway
Zeng, Y., Li, X., Tang, H., Chen, L., Yu, Q., Li, L., Chen, F., Li, L., Zheng, Y., Sun, J., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118498 · Cited by 25
Neolignans in Magnolia officinalis as natural anti-Alzheimer’s disease agents: A systematic review
Li, N., Liang, Y., Zhang, L., Xu, C., & Wang, L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102398 · Cited by 24
Insights into the Therapeutic and Pharmacological Properties of Resveratrol as a Nutraceutical Antioxidant Polyphenol in Health Promotion and Disease Prevention
Mohammadi, S., Moghadam, M. D., Nasiriasl, M., Akhzari, M., & Barazesh, M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328268507231218051058 · Cited by 22
Decoding paradoxical links of cytokine markers in cognition: Cross talk between physiology, inflammaging, and Alzheimer’s disease- related cognitive decline
Khan, H., Naseem, T., Kaushik, P., Narang, J., Khan, R., Panwar, S., & Parvez, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102535 · Cited by 21
Acyclic sesquiterpenes nerolidol and farnesol: mechanistic insights into their neuroprotective potential
Singh, A., & Singh, L. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00672-8 · Cited by 21
Zebrafish as a model organism to study sporadic Alzheimer's disease: Behavioural, biochemical and histological validation
Dhiman, N., Deshwal, S., Rishi, V., Singhal, N. K., & Sandhir, R. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115034 · Cited by 20
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 22
Unraveling the cGAS-STING pathway in Alzheimer’s disease: A new Frontier in neuroinflammation and therapeutic strategies
Kaur, A., & Aran, K. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.001 · Cited by 23
Neuroinflammation in Alzheimer’s disease: potential beneficial effects of vitamin D
Kouba, B. R., Camargo, A., & Rodrigues, A. L. S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01188-5 · Cited by 22
A review of MPTP-induced parkinsonism in adult zebrafish to explore pharmacological interventions for human Parkinson’s disease
Bagwell, E., & Larsen, J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1451845 · Cited by 22
Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
Singh, M., Ali, H., Jyothi, S. R., Kaur, I., Kumar, S., Sharma, N., Prasad, G. V. S., Pramanik, A., Almalki, W. H., & Imran, M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149165 · Cited by 18
The Role of Cytokines in Perioperative Neurocognitive Disorders: A Review in the Context of Anesthetic Care
Koh, H. J., & Joo, J. D. (2025) · Biomedicines · doi:10.3390/biomedicines13020506 · Cited by 18
Targeting LKB1–AMPK–SIRT1–induced autophagy and mitophagy pathways improves cerebrovascular homeostasis in APP/PS1 mice
Li, Y., Wang, T., Li, H., Jiang, Y., Shen, X., Kang, N., Guo, Z., Zhang, R., Lu, X., Kang, T., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.045 · Cited by 19
Viral-induced neuronal necroptosis: Detrimental to brain function and regulation by necroptosis inhibitors
Panda, S. P., Kesharwani, A., Mallick, S. P., Prasanth, D., Pasala, P. K., & Tatipamula, V. B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115591 · Cited by 18
Involvement of inflammasomes in the pathogenesis of Alzheimer's disease
Beder, N., Belkhelfa, M., & Leklou, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283677 · Cited by 20
Interplay of Neuroinflammation and Gut Microbiota Dysbiosis in Alzheimer’s Disease Using Diffusion Kurtosis Imaging Biomarker in 3 × Tg-AD Mouse Models
Palanivelu, L., Chang, C.-W., Li, S., Liang, Y., Lo, Y., & Chen, Y. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00063 · Cited by 17
Microglial Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapies
Erdağ, E., & Haskologlu, I. C. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2030029 · Cited by 20
A lifetime perspective on risk factors for cognitive decline with a special focus on early events
Kuhn, H. G., Skau, S., & Nyberg, J. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100217 · Cited by 20
Advancements in Pharmacological Treatment of Alzheimer’s Disease: The Advent of Disease-Modifying Therapies (DMTs)
Wang, Q., Chen, S., Wang, J., Shang, H., & Chen, X. (2024) · Brain Sciences · doi:10.3390/brainsci14100990 · Cited by 17
Neuro-inflammatory pathways in COVID-19-induced central nervous system injury: Implications for prevention and treatment strategies
Raza, M. L., Imam, M. H., Zehra, W., & Jamil, S. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114984 · Cited by 17
Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease
Xu, J., Song, W., Xu, Z., Danziger, M. M., Karavani, E., Zang, C., Chen, X., Li, Y., Paz, I. R., Gohel, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14373 · Cited by 17
Decoding Microglial Polarization and Metabolic Reprogramming in Neurodegenerative Diseases: Implications for Disease Progression and Therapy
Gao, R., Gao, Y., Su, W., & Wang, R. (2025) · Aging and Disease · doi:10.14336/ad.2024.1629 · Cited by 18
Unraveling the Complexity of Alzheimer’s Disease: Insights into Etiology and Advancements in Treatment Strategies
Khan, B., Iqbal, M. K., Khan, M. A., Khan, H. R., Kiyani, M. M., Bashir, S., & Li, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02337-4 · Cited by 17
Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets
Ahremenko, E. A., Andreev, A., Apushkin, D., & Korkotian, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411995 · Cited by 18
Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities
Li, H., Guan, M., Zhang, N.-N., Wang, Y., Liang, T., Wu, H., Wang, C., Sun, T., & Liu, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117011 · Cited by 16
The electrophysiological and neuropathological profiles of cerebellum in APPswe/PS1ΔE9 mice: A hypothesis on the role of cerebellum in Alzheimer's disease
Yu, H., Wang, M., Yang, Q., Xu, X., Zhang, R., Chen, X., & Le, W. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12853 · Cited by 17
miR-132–3p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer’s disease
Sbriscia, M., Spadoni, T., Ambrogini, P., Guescini, M., Agostini, R., Graciotti, L., Piacenza, F., Giuli, C., Cecati, M., Bonfigli, A. R., et al. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112063 · Cited by 15
Rotenone-Induced Mitochondrial Dysfunction, Neuroinflammation, Oxidative Stress, and Glial Activation in Parkinson’s and Alzheimer’s Diseases
Rubio, C., Serrano-GarcíA, N., Taddei, E., Castañeda-Saucedo, E., Romo, H., & Rubio‐Osornio, M. (2025) · Biocell · doi:10.32604/biocell.2025.066320 · Cited by 16
Modulation of Aging Diseases via RAGE Targets: A Dietary Intervention Review
Wu, Q., Yan, J., Zhang, Y., Ming, X., Chen, S., Zou, Z., Feng, N., & Xiao, J. (2025) · Advanced Science · doi:10.1002/advs.202510242 · Cited by 16
Biological determinants of blood-based biomarker levels in Alzheimer’s disease: role of nutrition, inflammation, and metabolic factors
Inamdar, A., Bugadannavar, P., Palled, M. S., Umarani, S., Salve, P. S., Gurupadayya, B., Patil, P. D., & Sharma, H. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1614962 · Cited by 21
The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
Kim, A., Lee, J., Moon, H., Kim, C., Yoo, M. Y., Park, W., Kim, W. D., & Seo, Y.-S. (2023) · Radiation Oncology Journal · doi:10.3857/roj.2023.00052 · Cited by 15
Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18
The role of monocytes and macrophages in the progression of Alzheimer’s disease
Nie, W., Yue, Y., & Hu, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1590909 · Cited by 15
Neuroinflammation and nutrition in Alzheimer’s disease
Park, H., Ni, M., & Le, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1622571 · Cited by 17
Oral Administration of Probiotic Bacteria Alleviates Tau Phosphorylation, Aβ Accumulation, Microglia Activation, and Memory Loss in 5xFAD Mice
Kim, Y. J., Mun, B.-R., Choi, K. Y., & Choi, W. (2024) · Brain Sciences · doi:10.3390/brainsci14030208 · Cited by 16
Protective role of Bacillus Calmette–Guérin vaccine in Alzheimer's disease progression: A systematic review and meta-analysis
Umar, T. P., Jain, N., Stevanny, B., Javed, B., Priandhana, A., Siburian, R., & Kostiks, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27425 · Cited by 14
Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer’s disease
Olney, K. C., Rabichow, B. E., Wojtas, A., Deture, M. A., McLean, P. J., Dickson, D. W., Chang, R. R., Ross, O. A., & Fryer, J. D. (2024) · Brain · doi:10.1093/brain/awae202 · Cited by 14
Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches
Yassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 14
Ginsenoside Rg1 attenuates Aβ1-42-induced microglial cell apoptosis and inflammation in Alzheimer’s disease via the GATA4/PDE4A/PI3K/AKT axis
Fang, H., Tian, H., Liu, J., Peng, T., & Wang, D. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.011 · Cited by 15
Self-citation
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Kopalli, S. R., Behl, T., Kyada, A., Rekha, M. M., Kundlas, M., Rani, P., Nathiya, D., Naidu, K. S., Gulati, M., Bhise, M. R., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.007 · Cited by 16
Immunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan
Fetarayani, D., Kahdina, M., Waitupu, A., Pratiwi, L., Ningtyas, M. C., Adytia, G. J., & Sutanto, H. (2025) · Medical Sciences · doi:10.3390/medsci13030100 · Cited by 17
Exploring the pharmacological mechanism of Bu-Wang San on Alzheimer's disease through multiple GEO datasets of the human hippocampus, network pharmacology, and metabolomics based on GC-MS and UPLC-Q/TOF-MS
Wang, H., Chao, L., Shen, S., You, P., Li, L., Chen, X., Hong, Z., & Chai, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119994 · Cited by 13
The role of peripheral innate immune cells in Alzheimer’s disease progression
Cao, Y., Tang, K., Ma, P., Zhang, R., Yang, Y., Li, T., Zhang, Y., & Peng, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1616939 · Cited by 15
Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders
Njoku, G. C., & Kanmogne, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189069 · Cited by 15

Authors: Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H.
Affiliations: First Affiliated Hospital of Soochow University (CN)
Corresponding author: Sun, Miao
Yang, Hao
ORCID: Wang, Bin
Sun, Miao
Yang, Hao
Venue: Frontiers in Immunology
Publisher: Frontiers Media SA
Published: 2022-04-26
Volume: 13
Pages: 856376-856376
ISSN: 1664-3224 (ISSN-L)
DOI: 10.3389/fimmu.2022.856376
PMC: PMC9086828
OpenAlex: W4281554374
Cited by: 351
References: 169
Citations by year: 2026: 70 · 2025: 148 · 2024: 88 · 2023: 41 · 2022: 4
FWCI: 7.24
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Frontiers in Immunology (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: National Natural Science Foundation of China (81,570,960, 81,974,244, 82071551, 2019YFA0802600)
Government of Jiangsu Province
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: microglia, Alzheimer's disease, neuroinflammation, neurodegeneration, amyloid-beta, tau hyperphosphorylation, neurofibrillary tangles, inflammatory cytokines, anti-inflammatory genes, phagocytosis, microglial homeostasis, therapeutic target
MeSH terms: Alzheimer Disease, Humans, Neurons, Amyloid beta-Peptides, Microglia, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks